Literature DB >> 35739133

Hepatic encephalopathy.

Dieter Häussinger1, Radha K Dhiman2, Vicente Felipo3, Boris Görg4, Rajiv Jalan5,6, Gerald Kircheis7, Manuela Merli8, Sara Montagnese9, Manuel Romero-Gomez10, Alfons Schnitzler11, Simon D Taylor-Robinson12, Hendrik Vilstrup13.   

Abstract

Hepatic encephalopathy (HE) is a prognostically relevant neuropsychiatric syndrome that occurs in the course of acute or chronic liver disease. Besides ascites and variceal bleeding, it is the most serious complication of decompensated liver cirrhosis. Ammonia and inflammation are major triggers for the appearance of HE, which in patients with liver cirrhosis involves pathophysiologically low-grade cerebral oedema with oxidative/nitrosative stress, inflammation and disturbances of oscillatory networks in the brain. Severity classification and diagnostic approaches regarding mild forms of HE are still a matter of debate. Current medical treatment predominantly involves lactulose and rifaximin following rigorous treatment of so-called known HE precipitating factors. New treatments based on an improved pathophysiological understanding are emerging.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35739133     DOI: 10.1038/s41572-022-00366-6

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   65.038


  316 in total

1.  Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

Authors:  Juan Cordoba; Meritxell Ventura-Cots; Macarena Simón-Talero; Àlex Amorós; Marco Pavesi; Hendrik Vilstrup; Paolo Angeli; Marco Domenicali; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

2.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

3.  High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.

Authors:  Oliviero Riggio; Cesare Efrati; Carlo Catalano; Federica Pediconi; Oriano Mecarelli; Neri Accornero; Francesca Nicolao; Stefania Angeloni; Andrea Masini; Lorenzo Ridola; Adolfo F Attili; Manuela Merli
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

4.  Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients.

Authors:  Rohit Sawhney; Peter Holland-Fischer; Matteo Rosselli; Rajeshwar P Mookerjee; Banwari Agarwal; Rajiv Jalan
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

5.  Factors Affecting Psychological Burden on the Informal Caregiver of Patients With Cirrhosis: Looking Beyond the Patient.

Authors:  Deepa Shrestha; Sahaj Rathi; Sandeep Grover; Sunil Taneja; Ajay Duseja; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2019-06-19

6.  Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study.

Authors:  Lea Ladegaard Grønkjær; Thomas Hoppe Sehstedt; Annelise Norlyk; Hendrik Vilstrup
Journal:  Gastroenterol Nurs       Date:  2018 Nov/Dec       Impact factor: 0.978

Review 7.  The brain in acute on chronic liver failure.

Authors:  Gavin Wright; Yalda Sharifi; Maria Jover-Cobos; Rajiv Jalan
Journal:  Metab Brain Dis       Date:  2014-05-20       Impact factor: 3.584

8.  Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers.

Authors:  Núria Fabrellas; Rebeca Moreira; Marta Carol; Marta Cervera; Gloria de Prada; Martina Perez; Elena Vazquez; Montse Sola; Raul Sancho; Adrià Juanola; Elisa Pose; Cristina Solé; Isabel Graupera; Elsa Solà; Patrick S Kamath; Pere Ginès
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

9.  Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Charlotte Wilhelmina Wernberg; Ove B Schaffalitzky de Muckadell; Jasmohan S Bajaj; Hendrik Vilstrup
Journal:  Hepatol Commun       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.